Products for Research Use Only
RegisterLogin

HX009

CAT: 0804-HY-P991085Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991085Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HX009 is a bispecific antibody targeting PD1 and CD47, but with weakened CD47 binding. HX009 blocks the functional of PD1/CD47. HX009 can be used for the study of non-Hodgkin’s lymphoma (NHL) [1].
UNSPSC
12352203
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Ke H, et al. HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models. Sci Rep. 2023 Apr 3;13 (1) :5419.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T9901A-797-01HX009
GTR18679037-01HX009 Antibody
A4014-1mgHx009 (Anti-CD47 & PD-1)
BIO0971SM-100ugAnti-human CD47 & PD-1 (Hx009 Biosimilar)
GTR18699406-01Anti-CD47 & PD-1 Reference Antibody (Hx009 Biosimilar)
HC359386-01Research Grade Anti-CD47 & PD-1 Bispecific Antibody (Hx009)
A137312Anti-CD47 & PD-1 Bispecific Antibody (Hx009) Biosimilar (Monoclonal, IgG-VHH)

Popular Products